EBC Financial Group Expands Asset Management Capabilities with Second Australian Financial Services Licence 16-10-2024, 07:00

Junshi Biosciences Announces Toripalimab plus Chemotherapy Significantly Improved Event-free Survival (EFS) versus Chemotherapy as Perioperative Treatment for Resectable Stage III Non-small Cell Lung Cancer (NSCLC) in Phase 3 Neotorch Study 21-04-2023, 03:01

Deriv recognised as “Most Innovative Broker - MEA 2025” 20-01-2025, 19:07